Globavir Biosciences
A biopharmaceutical company creating novel therapeutics and diagnostic tool for treating infectious disease.
All edits by Neelam Jhaveri
Edits on 14 Jul, 2020
Edits made to:
Article (+6/-6 characters)
Article
On January 21, 2015 Globavir Biosciences announced raising $4 million in venture funding from StartXStartX, Stanford University Venture Fund, and Sorrento Therapeutics.
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.